NCT03074019View on ClinicalTrials.gov

Pilot Study on the Effect of a XOS95 on the Human Gut Microbiome

NACompletedINTERVENTIONAL

Enrollment

75

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

August 31, 2017

Study Completion Date

September 28, 2017

Conditions

Healthy

Interventions

DIETARY_SUPPLEMENT

Xylooligosaccacharide

XOS95 powder

DIETARY_SUPPLEMENT

Maltodextrin

Maltodextrin powder

Trial Locations (1)

N1G 0B4

Nutrasource Diagnostics Inc., Guelph

Sponsors

Lead Sponsor

Prenexus Health

All Listed Sponsors

collaborator

Nutrasource Pharmaceutical and Nutraceutical Services, Inc.

NETWORK

lead

Prenexus Health

INDUSTRY

NCT03074019 - Pilot Study on the Effect of a XOS95 on the Human Gut Microbiome | Biotech Hunter | Biotech Hunter